Search
for
Sort by
Research 751–780 of 1000+
- A case report of alopecia totalis associated with permanent hair dye use
- Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus
- Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Mesenchymal Stem Cells for the Treatment of Skin Diseases
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Stem cell-based therapies for alopecia areata: a narrative review
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Stem-cell therapy in dermatology – Challenges and opportunities
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- New Treatment Options for Alopecia Areata
- Recent advances in the genetics of alopecia areata
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia
- When the skin meets the bowel: About a case